News about Global Pharma

Lupin and Honeywell Advance Collaboration to Introduce HFO Technology in Inhalers

Lupin and Honeywell Advance Collaboration to Introduce HFO Technology in Inhalers

Lupin is set to become first Indian company to fully integrate Honeywell’s Solstice Air in its respiratory inhalers at scale, redefining respiratory care with near-zero global warming potential propellants.

Global Pharma | 20/05/2025 | By Manvi 302

BLA for Novavax's COVID-19 Vaccine Secures USFDA Approval

BLA for Novavax's COVID-19 Vaccine Secures USFDA Approval

Novavax has received US FDA approval for the Biologics License Application (BLA) for its COVID-19 vaccine Nuvaxovid, targeting high-risk individuals aged 12 and above, triggering a USD 175 million milestone payment from Sanofi under their licensing agreement.

Global Pharma | 19/05/2025 | By Manvi 433

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Appoints Slawek Kierner as CDO - Smart Connected Care

Olympus Corporation (Olympus) announced the appointment of Slawek Kierner to the role of Chief Digital Officer - Smart Connected Care (CDO-SCC), effective immediately.

Global Pharma | 19/05/2025 | By Manvi 214

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Trax Surgical Receives FDA Clearance for LINKT Compression Staple System

Massachusetts based Trax Surgical, LLC, an orthopedic product development and distribution company principally serving the needs of the orthopedic extremities market, announced that they received FDA 510(k) clearance to market the LINKT™ Compression Staple System.

Global Pharma | 19/05/2025 | By Manvi 179

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India's Pharma Sector Records 7.8 Percent Growth in April 2025, Catering to 20 Percent of Global Need

India’s pharmaceutical industry recorded 7.8 percent year-on-year growth in April 2025, driven by global demand, new product launches, and robust government initiatives positioning the country as a global hub for affordable, high-quality healthcare.

Global Pharma | 19/05/2025 | By Manvi 902

Fzata Announces Joining of Gianna Arnold on Board of Directors

Fzata Announces Joining of Gianna Arnold on Board of Directors

The pharmaceutical company, Fzata, Inc., informed about the appointment of Gianna Arnold on the Board of Directors. The company developed a next-generation oral biologics modality called Bioengineered Probiotic Yeast Medicines (BioPYM).

Global Pharma | 19/05/2025 | By Manvi 301

Endo Expands ADRENALIN RTU Premixed Bag Portfolio with New Concentration Option

Endo Expands ADRENALIN RTU Premixed Bag Portfolio with New Concentration Option

Endo, Inc. has announced the launch of an FDA-approved ADRENALIN, currently the only commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag.

Global Pharma | 17/05/2025 | By Manvi 231

ISSS Endorses Hyoid Suspension as Safe, Effective Treatment for Obstructive Sleep Apnea

ISSS Endorses Hyoid Suspension as Safe, Effective Treatment for Obstructive Sleep Apnea

Following a rigorous review of clinical research, the International Surgical Sleep Society (ISSS) recently published a position statement supporting hyoid suspension as a safe and effective approach in the medical and surgical management of obstructive sleep apnea (OSA).

Global Pharma | 17/05/2025 | By Manvi 497

Maness Veteran Medical's NEUBIE Device Now Available to VA, DoD via Federal Supply Schedule

Maness Veteran Medical's NEUBIE Device Now Available to VA, DoD via Federal Supply Schedule

Maness Veteran Medical (MVM) announce a major step forward in the future of veteran care: the NEUBIE (Neuro-Bio-Electric Stimulator) device is now officially available through the Federal Supply Schedule (FSS), contract 36F79725D0083.

Global Pharma | 17/05/2025 | By Manvi 348

Sun Pharma Secures FDA Approval for Next-Generation BLU-U Blue Light Therapy Device for Actinic Keratosis

Sun Pharma Secures FDA Approval for Next-Generation BLU-U Blue Light Therapy Device for Actinic Keratosis

Sun Pharma has received FDA approval for its next-generation LED BLU-U Blue Light Photodynamic Therapy Illuminator for treating actinic keratosis.

Global Pharma | 17/05/2025 | By Manvi 537

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members